Kronox Lab Sciences IPO Subscription Status, Rate

Kronox Lab Sciences IPO Allotment Status Online

Kronox Lab Sciences IPO Subscription Status: Kronox Lab Sciences IPO is Open on 3 June, 2024 and Close on 5 June, 2024. Kronox Lab Sciences  IPO to Raise 9,600,000 Shares (Rs. 130.56 Cr) via IPO. The Fresh Issue of 9,600,000 Shares (Rs. 130.56 Cr).

  • The Retail Quota is 35%
  • QIB is 50%
  • NII is 15%

 

Kronox Lab Sciences IPO is an Mainline IPO and Listed on NSE & BSE. Kronox Lab Sciences  IPO Price Band is Fixed at ₹129 to ₹136 Equity Share. Kronox Lab Sciences  IPO Lot Size is 110 Shares.

About Kronox Lab Sciences IPO :

  • Kronox Lab Sciences Products Are Manufactured By Industry Standards Like IP, BP, EP, JP, USP, FCC, LR, AR, And ACS In Addition To Custom Manufacturing Specifications, Which Differ From The Industry Standards, Required By Our Customers In Select Cases. We Manufacture High-Purity Speciality Fine Chemicals In Various Grades In Particle Sizes Ranging From 10 Mesh To 100 Mesh. We Believe That Our Focus On Product Development, Diversity In Product Offerings, Meeting Quality Standards And Customer Specifications And Continuous Process Improvement Led To Repeat Orders From Our Customers Over The Years.
  • Our Range Of More Than 185 Products Spanning Across The Family Of Phosphate, Sulphate, Acetate, Chloride, Citrate, Nitrates, Nitrites, Carbonate, EDTA Derivatives, Hydroxide, Succinate, Gluconate, Among Others Are Supplied To Customers In India And More Than 20 Countries Globally.

 

Kronox Lab Sciences IPO Subscription Status, Rate bid times

Inv Category Shares Reserved No. of Shares bid for No. of Times (Subscription)
Qualified Buyers (QIBs) 19,14,000 17,04,09,360 89.03
Non Institutional Buyers (NIIs) 14,35,500 43,34,01,320 301.88
Retail Individual Buyers (RIIs) 33,49,500 18,16,43,110 54.10
BNII 9,57,000 30,84,06,670 322.26
SNII 4,78,500 12,49,94,650 261.11
Total 66,99,000 78,54,53,790 117.18

 

 

 

Ztech India Subscription Status day-by-day-

Categories 3 June 4 June 5 June
QIB 1.11 3.39 89.03
NII 19.87 52.90 301.92
RII 12.90 24.50 54.23
Total 11.02 24.56 117.25

 

 

Kronox Lab Sciences Investor Categories

  • Qualified Institutional Buyers (QIB).
  • Non- Institutional Investors (NII).
  • Retail individual Investors (RII).
  • Employee (EMP).
  • Others (Eligible Shareholders).

Who Is QIB In IPO?

QIB Stands For “Qualified Institutional Buyer” In The Context Of An IPO (Initial Public Offering). QIBs Are A Category Of Institutional Investors Who Are Considered Financially Sophisticated And Meet Certain Regulatory Criteria For Participating In Capital Markets. In The Context Of An IPO, QIBs Play A Significant Role As They Contribute To The Overall Demand For Shares And Help Determine The Success Of The Offering.

Who Is NII In IPO?

NII Stands For “Non-Institutional Investors” In The Context Of An IPO (Initial Public Offering). Non-Institutional Investors Are A Category Of Investors Who Participate In The IPO Alongside Institutional Investors And Retail Investors. NII Typically Includes High Net Worth Individuals (HNIs), Corporate Bodies, Trusts, And Other Entities That Are Not Classified As Institutional Investors But Have The Financial Capacity To Invest Significant Amounts In The IPO.

Who Is RII In IPO?

RII Stands For “Retail Individual Investor” In The Context Of An IPO (Initial Public Offering). Retail Individual Investors Are Individual Investors Who Participate In The IPO Alongside Institutional Investors And Non-Institutional Investors. RII Typically Includes Individual Investors Who Do Not Meet The Criteria To Be Classified As Institutional Investors Or Non-Institutional Investors.

Who Is EMP In IPO?

“EMP” In The Context Of An IPO (Initial Public Offering) Typically Stands For “Employee.” In Some IPOs, A Certain Portion Of The Shares May Be Reserved For Allocation To Employees Of The Company Going Public. These Employees Are Often Referred To As “Employee Shareholders” Or “Employee Participants” (EMP).

Kronox Lab Sciences Review From MoneyMintIdea –

  • May Apply

 

Leave a Comment

Facebook
Twitter
WhatsApp
Telegram
LinkedIn